Internet of Medical Things (IoMT) for Alzheimer Patient’s Outcome

Thangavel Lakshmipriya; Subash C.B. Gopinath

doi:10.2174/0118715273371149250218081425

ISSN: 1871-5273
E-ISSN: 1996-3181

Internet of Medical Things (IoMT) for Alzheimer Patient’s Outcome
Authors: Thangavel Lakshmipriya¹ and Subash C.B. Gopinath^2,3
View Affiliations Hide Affiliations

¹ Center for Global Health Research, Saveetha Medical College & Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai 602105, Tamil Nadu, India ; ² Faculty of Chemical Engineering & Technology, Universiti Malaysia Perlis, 02600 Arau, Perlis, Malaysia; ³ Institute of Nano Electronic Engineering, Universiti Malaysia Perlis, 01000 Kangar, Perlis, Malaysia
Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Volume 24, Issue 7, Jul 2025, p. 491 - 493
DOI: https://doi.org/10.2174/0118715273371149250218081425
- Received: 13 Nov 2024
- Accepted: 27 Dec 2024
- Available online: 21 Feb 2025

Abstract

The Internet of Medical Things (IoMT) is a network system that connects devices with medical and healthcare for the ultimate aim of collecting, transmitting, and analyzing the acquired data in the presence of the internet. A wide range of equipment and monitoring systems have been generated with IoMT, and they permit real-time monitoring, sharing the data, analysis, patient care, and for efficient operation. At the advanced level, it is highly facilitated with remote patient digital monitoring and telemedicine. IoMT has a significant potential to enhance the care of Alzheimer’s disease patients to overcome issues with a progressive neurological condition, memory loss, cognition, and behavior. This study aims to bring the potential of the Internet of Things (IoT) to be implemented in the Internet of Medical Things (IoMT), with a special focus on Alzheimer’s disease patients.

Article metrics loading...

/content/journals/cnsnddt/10.2174/0118715273371149250218081425

2025-02-21

2025-10-26

From This Site

/content/journals/cnsnddt/10.2174/0118715273371149250218081425

dcterms_title,dcterms_subject,pub_keyword

-contentType:Contributor -contentType:Concept -contentType:Institution

10

5

Full text loading...

References

LiC. HuX. ZhangL. The IoT-based heart disease monitoring system for pervasive healthcare service.Proc Comp Sci20171122328233410.1016/j.procs.2017.08.265
[Google Scholar]
HuangC. WangJ. WangS. ZhangY. Internet of medical things: A systematic review.Neurocomputing202355712671910.1016/j.neucom.2023.126719
[Google Scholar]
Al-kuraishyH.M. JabirM.S. AlbuhadilyA.K. Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle.Ageing Res. Rev.20249510223310.1016/j.arr.2024.102233 38360180
[Google Scholar]
AliN.H. Al-kuraishyH.M. Al-GareebA.I. The probable role of tissue plasminogen activator/neuroserpin axis in Alzheimer’s disease: A new perspective.Acta Neurol. Belg.2024124237738810.1007/s13760‑023‑02403‑x 37917293
[Google Scholar]
Al-kuraishyH.M. JabirM.S. AlbuhadilyA.K. Al-GareebA.I. RafeeqM.F. The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation.Ageing Res. Rev.20239110208410.1016/j.arr.2023.102084 37802319
[Google Scholar]
Al-KuraishyH.M. Al-GareebA.I. AlsayeghA.A. A potential link between visceral obesity and risk of alzheimer’s disease.Neurochem. Res.202348374576610.1007/s11064‑022‑03817‑4 36409447
[Google Scholar]
QiuZ. ZhangX. JiaN. Zeolite nanomaterial-modified dielectrode oxide surface for diagnosing Alzheimer’s disease by dual molecular probed impedance sensor.Turk Biyokim. Derg.202448666867410.1515/tjb‑2023‑0079
[Google Scholar]
2023 Alzheimer’s disease facts and figures.Alzheimers Dement.20231941598169510.1002/alz.13016 36918389
[Google Scholar]
SheikhtaheriA. SabermahaniF. Applications and outcomes of internet of things for patients with alzheimer’s disease/dementia: A scoping review.BioMed Res. Int.202220221627418510.1155/2022/6274185 35342749
[Google Scholar]
MachadoS.D. TavaresJ.E.R. MartinsM.G. BarbosaJ.L.V. GonzálezG.V. LeithardtV.R.Q. Ambient intelligence based on iot for assisting people with alzheimer’s disease through context histories.Electronics20211011126010.3390/electronics10111260
[Google Scholar]
ArunachalamR. SunithaG. ShuklaS.K. pandey SN, Urooj S, Rawat S. A smart Alzheimer’s patient monitoring system with IoT-assisted technology through enhanced deep learning approach.Knowl. Inf. Syst.202365125561559910.1007/s10115‑023‑01890‑x
[Google Scholar]
EbrahemA.T. Mawfaq Mohamedsheet Al-HatabM. Al-JabbarE.Y.A. AlkhaledW.H. Al-SawaffZ.H. Using IoT technology for monitoring Alzheimer’s and elderly patients.Indones. J. Electr. Eng. Comput. Sci.202331298610.11591/ijeecs.v31.i2.pp986‑994
[Google Scholar]
ChongZ.H.K. TeeY.X. TohL.J. PhangS.J. LiewJ.Y. Predicting potential Alzheimer medical condition in elderly using IOT sensors - Case study.Proceedings of the IRC Conference on Science, Engineering, and Technology201716
[Google Scholar]

/content/journals/cnsnddt/10.2174/0118715273371149250218081425

Internet of Medical Things (IoMT) for Alzheimer Patient’s Outcome

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) 24, 491 (2025); https://doi.org/10.2174/0118715273371149250218081425

/content/journals/cnsnddt/10.2174/0118715273371149250218081425

Data & Media loading...

Article Type: Review Article

Keyword(s): Alzheimer’s disease; amyloid beta; brain disorder; deep learning; dementia; Internet of medical things

Internet of Medical Things (IoMT) for Alzheimer Patient’s Outcome

Abstract

From This Site

Most Read This Month

Most Cited Most Cited RSS feed

A Retrospective, Multi-Center Cohort Study Evaluating the Severity- Related Effects of Cerebrolysin Treatment on Clinical Outcomes in Traumatic Brain Injury

CypD: The Key to the Death Door

Is Mental Practice an Effective Adjunct Therapeutic Strategy for Upper Limb Motor Restoration After Stroke? A Systematic Review and Meta- Analysis

Targeting Brain Nicotinic Acetylcholine Receptors to Treat Major Depression and Co-Morbid Alcohol or Nicotine Addiction

Drug Targets of Migraine and Neuropathy: Treatment of Hyperexcitability

Testosterone Replacement Therapy in Older Male Subjective Memory Complainers: Double-Blind Randomized Crossover Placebo-Controlled Clinical Trial of Physiological Assessment and Safety

Lower Uric Acid Linked with Cognitive Dysfunction in the Elderly

Laboratory, Clinical and Therapeutic Features of Respiratory Panic Disorder Subtype

Tremor and Rigidity in Patients with Parkinson’s Disease: Emphasis on Epidemiology, Pathophysiology and Contributing Factors

Poly(ADP-Ribose)Polymerase 1 (PARP-1) Activation and Ca2+ Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?